Novel Proline derivatives for Treating COVID-19.
Curr Med Chem
; 2022 Sep 22.
Article
in English
| MEDLINE | ID: covidwho-2229370
ABSTRACT
COVID-19 is a contagious disease. Paxlovid, a combination of Nirmatrelvir and Ritonavir, was granted emergency use authorization by the United States Food and Drug Administration (FDA) for the treatment of COVID-19 on December 22, 2021. These are peptidomimetic coronavirus main protease inhibitors. Nirmatrelvir is a proline derivative. The present patent describes similar proline- like compounds, their preparation, use, and pharmaceutical composition, and treatment.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal subject:
Chemistry
Year:
2022
Document Type:
Article
Affiliation country:
0929867329666220922095343
Similar
MEDLINE
...
LILACS
LIS